Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
Yanwei Li, Wei Zhou, Yang Li, et al.
Pharmacological Research (2020) Vol. 157, pp. 104833-104833
Open Access | Times Cited: 375

Showing 26-50 of 375 citing articles:

Sex‐related differences in COVID‐19 lethality
Cláudia Penna, Valentina Mercurio, Carlo G. Tocchetti, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4375-4385
Open Access | Times Cited: 96
ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
Pasquale Pagliaro, Cláudia Penna
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 95
COVID-19 Compared to Other Pandemic Diseases
Silvio Pitlik
Rambam Maimonides Medical Journal (2020) Vol. 11, Iss. 3, pp. e0027-e0027
Open Access | Times Cited: 93
Covid-19 and Diabetes: A Complex Bidirectional Relationship
Hermine Muniangi-Muhitu, Elina Akalestou, Victoria Salem, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 92
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Eugenio Cavalli, Alessia Bramanti, Rosella Ciurleo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 3, pp. 903-912
Open Access | Times Cited: 85
Why Does the Severity of COVID-19 Differ With Age?
Petra Zimmermann, Nigel Curtis
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 2, pp. e36-e45
Open Access | Times Cited: 79
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1687-1687
Open Access | Times Cited: 75
A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19
Pravin T. Goud, David Bai, Husam M. Abu‐Soud
International Journal of Biological Sciences (2020) Vol. 17, Iss. 1, pp. 62-72
Open Access | Times Cited: 71
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
Giorgio Costagliola, Erika Spada, Rita Consolini
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 2, pp. 331-339
Open Access | Times Cited: 70
SARS-CoV-2: is there neuroinvasion?
Conor McQuaid, Molly Brady, Rashid Deane
Fluids and Barriers of the CNS (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 272-272
Open Access | Times Cited: 61
Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
Chen Yang, Yu Zhang, Xia Zeng, et al.
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 3, pp. 185-196
Open Access | Times Cited: 60
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
Ceren Güney, Fatma Akar
Journal of Pharmacy & Pharmaceutical Sciences (2021) Vol. 24, pp. 84-93
Open Access | Times Cited: 59
Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection
Menizibeya O. Welcome, Nikos E. Mastorakis
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 939-963
Open Access | Times Cited: 58
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
Reza Elahi, Parsa Karami, Amir Hossein Heidary, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108536-108536
Open Access | Times Cited: 45
Is Covid-19 Severity Associated With ACE2 Degradation?
Ugo Bastolla, Patrick Chambers, David Abia, et al.
Frontiers in Drug Discovery (2022) Vol. 1
Open Access | Times Cited: 39
Extracellular vesicles derived from mesenchymal stem cells — a novel therapeutic tool in infectious diseases
Tasaduq Manzoor, Afnan Saleem, Nida Farooq, et al.
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 39
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”
Jakub Sadowski, Samanta Anna Ostrowska, Tomasz Klaudel, et al.
Journal of NeuroVirology (2025)
Closed Access | Times Cited: 1
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
Gabriele Pagani, Federico Conti, Andrea Giacomelli, et al.
Journal of Infection (2020) Vol. 81, Iss. 6, pp. e10-e12
Open Access | Times Cited: 63
SARS‐CoV‐2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project
Andrea Salonia, Giovanni Corona, Aleksander Giwercman, et al.
Andrology (2020) Vol. 9, Iss. 1, pp. 19-22
Open Access | Times Cited: 62
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
Murat Selçuk, Tufan Çınar, Muhammed Keskin, et al.
Clinical and Experimental Hypertension (2020) Vol. 42, Iss. 8, pp. 738-742
Closed Access | Times Cited: 61
Promoting attachment between parents and neonates despite the COVID‐19 pandemic
Charlotte Tscherning, Jacques Sizun, Pierre Kuhn
Acta Paediatrica (2020) Vol. 109, Iss. 10, pp. 1937-1943
Open Access | Times Cited: 61
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
Kun Han, Robert V. Blair, Naoki Iwanaga, et al.
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 1, pp. 79-88
Open Access | Times Cited: 58
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1312-1312
Open Access | Times Cited: 57
How to deal with coronavirus disease 2019: A comprehensive narrative review about oral involvement of the disease
Giorgia Capocasale, Riccardo Nocini, P. Faccioni, et al.
Clinical and Experimental Dental Research (2020) Vol. 7, Iss. 1, pp. 101-108
Open Access | Times Cited: 56

Scroll to top